APLLTD.NS

Alembic Pharmaceuticals Limited · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$107.43B

PE Ratio

49.63191364317841

EV to Ebitda

—

Earnings Yield

166687113.24%

Revenue (TTM)

$684.4M

Net Income (TTM)

$24.2M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

18.70%

Profit Margin

3.73%

Return on Equity

—

Debt to Equity Ratio

0.1354311730571284

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$107.43B

Revenue TTM$684.4M

Shares Outstanding196.6M

Float58829340

Insider Ownership70.71%

Institutional Ownership15.12%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)18.70%

Rev Growth Est 1Y Forward0.1110

EPS Growth (Quarterly YoY)-31.00%

EPS Growth Est Quarterly5.57

LT EPS Growth Estimates48.70%

Operations14 fields›

Revenue TTM$684.4M

Gross Margin TTM67.25%

Gross Margin (Quarterly)69.85%

Operating Margin TTM5.86%

Operating Margin (Quarterly)12.08%

Profit Margin TTM3.73%

Profit Margin (Quarterly)8.08%

Net Income TTM$24.2M

EPS TTM10.75

EBIT Margin TTM12.00%

EBITDA TTM$82.1M

Capex % of Revenue TTM11.66%

Capital Expenditures$79.8M

FCF % of Revenue (Quarterly)2.24%

Efficiency1 fields›

ROA2.95%

Valuation7 fields›

P/E (TTM)49.63191364317841

P/E Forward0

EV/Revenues (TTM)2.3196

Price To Book1.9397652518520978

Earnings Yield166687113.24%

Dividend Yield0.00%

Payout Ratio87.49%

Liquidity6 fields›

Cash Per Share4.716371504274507

Current Ratio1.6191816095168188

Total Assets$70986.70T

Shareholders Equity$51198.70T

Debt to Equity0.1354311730571284

Interest Expense$425.0M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio87.49%

Earnings Yield166687113.24%